Webdisclosure.com

Search

VALNEVA (EPA:VLA) Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Directive transparence : information réglementée

31/01/2022 22:15